This ICR is
approved for 3 years. However, FDA is reminded that #13 of the
supporting statement should reflect capital/maintenance costs, not
the wage cost of reporting.
Inventory as of this Action
Requested
Previously Approved
08/31/2012
36 Months From Approved
08/31/2009
23
0
11
184
0
88
0
0
0
This collection of information
describes the process for formally reoslving scientific and
procedural disputes in the Center for Drug Evaluation and Research
(CDER) and the Center for Biologics Evaluation and Research (CBER)
that cannot be resolved at the division level.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.